Division of Pediatric Hematology/Oncology

Clinical Trials

Other

• Osteonecrosis, thrombophilia and dyslipidemia in pediatric patients with hemoglobinopathies and lymphoid mailgnancies
  Principal investigator: Anjulika Chawla, MD

• Parental needs for information about neurocognitive risks associated with pediatric cancer and its treatment
  Principal investigators: Christine Trask, PhD; Elissa Jelalian, PhD; Peter Manley, MD; Cindy Schwartz, MD; Jennifer Green-Welch, MD

Solid Tumor (Other)

• DFCI04-343A: Phase II: Anti-angiogenic chemotherapy: Trial of the Oral 5 drug regiman (Thalidomide, Celecoxib, Fenofibrate, Etoposide and Cyclophosphamide) in patients with relapsed or progressive cancer
  Principal investigator: Peter Manley, MD

For more information about these clincial trials and how to participate, please call 401-444-HOPE (4673). For general information about clinical trials please visit the National Cancer Institute.

Back